Provided by Tiger Trade Technology Pte. Ltd.

Niagen Bioscience

3.29
+0.08002.49%
Post-market: 3.290.00000.00%19:38 EDT
Volume:498.29K
Turnover:1.63M
Market Cap:262.03M
PE:17.30
High:3.30
Open:3.22
Low:3.20
Close:3.21
52wk High:10.52
52wk Low:2.87
Shares:79.64M
Float Shares:55.82M
Volume Ratio:1.32
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1901
EPS(LYR):0.2000
ROE:21.80%
ROA:5.44%
PB:3.18
PE(LYR):16.45

Loading ...

Niagen Bioscience to Present at NASDAQ X LD Micro Inaugural SF Summit

Reuters
·
Aug 26

Niagen Bioscience Expands Tru Niagen Retail Distribution Through GNC, Sam’s Club Partnership

Reuters
·
Aug 20

NAGE Shines Spotlight on New NAD+ Skin‑Aging Trial as Cosmetic Demand Heats Up

TIPRANKS
·
Aug 20

Niagen Bioscience to Present at Midwest IDEAS Investor Conference

Reuters
·
Aug 12

Is Niagen Bioscience (NAGE) Quietly Recasting Its Brand Around E‑Commerce Scale And Clinical Proof

Simply Wall St.
·
Aug 07

Niagen Bioscience CFO highlights telehealth as ‘high-expectation growth channel’

TIPRANKS
·
Aug 07

Meet Niagen Bioscience: Fly exclusive interview with CFO Ozan Pamir

TIPRANKS
·
Aug 07

Bananas, Bread, Bones…Walmart Seals Healthy Aging Deal With Niagen Bioscience

TIPRANKS
·
Aug 06

Niagen Bioscience announces Tru Niagen is now available at Walmart

TIPRANKS
·
Aug 06

Niagen Bioscience price target lowered to $10 from $12 at Roth Capital

TIPRANKS
·
Aug 05

Niagen Bioscience Posts Investor Presentation Focused on NAD+ Science and Healthy-Aging Products

Reuters
·
Aug 05

Niagen Bioscience Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Niagen Bioscience Q2 Net Sales Fall, Missing Estimates

Reuters
·
Aug 05

Niagen Bioscience Q2 EPS $0.01 Misses $0.02 Estimate, Sales $29.785M Miss $30.690M Estimate

Benzinga Earnings
·
Aug 05

Niagen Bioscience: Ingredient Business Expected to be Lower than Prior Year as Some Commercial Partners Continue to Face More Competitive Market

THOMSON REUTERS
·
Aug 05

Niagen Bioscience: Expect Niagen Plus Growth & New Skincare Partnerships to Become Meaningful Contributors Beginning 2027

THOMSON REUTERS
·
Aug 05

Niagen Bioscience Inc Q2 Net Income USD 963 Thousand

THOMSON REUTERS
·
Aug 05

Niagen Bioscience Inc Q2 EPS USD 0.01 VS. Ibes Estimate USD 0.01

THOMSON REUTERS
·
Aug 05

Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 05

Niagen Bioscience Taps Evotec to Advance Preclinical Development of Nb4168 Rare-Disease Candidate

Reuters
·
Aug 03